You are now leaving this website.
Are you sure?
NO
YES
  1. EVENTS - 14-12-2017

    KEDRABâ„¢: Pivotal Phase 2/3 Data presented at RITA Conference

    Kedrion Biopharma and Kamada Received FDA Approval of the Product in Q3 2017

    read more 
For more information please contact: [email protected]